A non-invasive colorectal cancer screening tool based on bacterial fecal biomarkers can help reduce false-positive results when used with a fecal immunochemical test, according to study results.
Jesús Garcia-Gil, PhD, of The Universitat de Girona in Spain, and colleagues wrote that they sought to develop this new tool — called risk assessment of intestinal disease for colorectal cancer (RAID-CRC) — based on emerging evidence of the impact of bacteria on the development of CRC.
“Recently, it has been proven that bacterial communities in the intestinal mucosa of CRC

Source link